J 2025

Impact of diabetes on epicardial reperfusion and mortality in a contemporary STEMI population undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

GIUSEPPE, De Luca; Magdy ALGOWHARY; Berat UGUZ; Dinaldo C OLIVEIRA; Vladimir GANYUKOV et al.

Základní údaje

Originální název

Impact of diabetes on epicardial reperfusion and mortality in a contemporary STEMI population undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

Autoři

GIUSEPPE, De Luca; Magdy ALGOWHARY; Berat UGUZ; Dinaldo C OLIVEIRA; Vladimir GANYUKOV; Zan ZIMBAKOV; Miha CERCEK; Lisette Okkels JENSEN; Poay Huan LOH; Lucian CALMAC; Roura i Ferrer GERARD; Alexandre QUADROS; Marek MILEWSKI; Fortunato Scotto D'UCCIO; von Birgelen CLEMENS; Francesco VERSACI; Ten Berg JURRIEN; Gianni CASELLA; Aaron Wong Sung LUNG; Petr KALA; Jose Luis Diez GIL; Xavier CARRILLO; Maurits DIRKSEN; Victor M BECERRA-MUNOZ; Michael Kang-yin LEE; Dafsah Arifa JUZAR; Rodrigo de Moura JOAQUIM; Roberto PALADINO; Davor MILICIC; Periklis DAVLOUROS; Nikola BAKRACESKI; Filippo ZILIO; Luca DONAZZAN; Adriaan KRAAIJEVELD; Gennaro GALASSO; Lux ARPAD; Marinucci LUCIA; Guiducci VINCENZO; Maurizio MENICHELLI; Alessandra SCOCCIA; Aylin Hatice YAMAC; Kadir Ugur MERT; Xacobe Flores RIOS; Tomas KOVARNIK; Michal KIDAWA; Jose MOREU; Vincent FLAVIEN; Enrico FABRIS; Inigo Lozano MARTINEZ-LUENGAS; Francisco Bosa OJEDA; Robert RODRIGUEZ-SANCHEZ; Gianluca CAIAZZO; Giuseppe CIRRINCIONE; Hsien-Li KAO; Juan Sanchis FORES; Luigi VIGNALI; Helder PEREIRA; Stephane MANZO; Santiago ORDONEZ; Alev Arat OZKAN; Bruno SCHELLER; Heidi LEHTOLA; Rui TELES; Christos MANTIS; Ylitalo ANTTI; Joao Antonio Brum SILVEIRA; Rodrigo ZONI; Ivan BESSONOV; Stefano SAVONITTO; George KOCHIADAKIS; Dimitrios ALEXOPULOS; Carlos E URIBE; John KANAKAKIS; Benjamin FAURIE; Gabriele GABRIELLI; Alejandro Gutierrez BARRIOS; Juan Pablo BACHINI; Alex ROCHA; Frankie Chor-Cheung TAM; Alfredo RODRIGUEZ; Antonia Anna LUKITO; Anne BELLEMAIN-APPAIX; Gustavo PESSAH; Giuliana CORTESE; Guido PARODI; Mohammed Abed BURGADHA; Elvin KEDHI; Pablo LAMELAS; Harry SURYAPRANATA; Matteo NARDIN a Monica VERDOIA

Vydání

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, London, ELSEVIER SCI LTD, 2025, 0939-4753

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.700 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00141532

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

Diabetes mellitus; ST-Segment myocardial infarction; PCI; COVID

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 7. 7. 2025 14:44, Mgr. Tereza Miškechová

Anotace

V originále

Background and aim Diabetes has been shown in last decades to be associated with a significantly higher mortality among patients with ST-segment elevation myocardial infarction (STEMI) treated with primary PCI (PPCI). Therefore, the aim of current study was to evaluate the impact of diabetes on times delays, reperfusion and mortality in a contemporary STEMI population undergoing PPCI, including treatment during the COVID pandemic. Methods and results The ISACS-STEMI COVID-19 is a large-scale retrospective multicenter registry involving PPCI centers from Europe, Latin America, South-East Asia and North-Africa, including patients treated from 1st of March until June 30, 2019 and 2020. Primary study endpoint of this analysis was in-hospital mortality. Secondary endpoints were postprocedural TIMI 0-2 flow and 30-day mortality. Our population is represented by 16083 STEMI patients. A total of 3812 (23,7 %) patients suffered from diabetes. They were older, more often males as compared to non-diabetes. Diabetic patients were less often active smokers and had less often a positive family history of CAD, but they were more often affected by hypertension and hypercholesterolemia, with higher prevalence of previous STEMI and previous CABG. Diabetic patients had longer ischemia time, had more often anterior MI, cardiogenic shock, rescue PCI and multivessel disease. They had less often out-of-hospital cardiac arrest and in-stent thrombosis, received more often a mechanical support, received less often a coronary stent and DES. Diabetes was associated with a significantly impaired postprocedural TIMI flow (TIMI 0-2: 9.8 % vs 7.2 %, adjusted OR [95 % CI] = 1.17 [1.02-1.38], p = 0.024) and higher mortality (in-hospital: 9.1 % vs 4.8 %, Adjusted OR [95 % CI] = 1.70 [1.43-2.02], p < 0.001; 30-day mortality: 10.8 % vs 6 %, Adjusted HR [95 % CI] = 1.46 [1.26-1.68], p < 0.001) as compared to non-diabetes, particularly during the pandemic. Conclusions Our study showed that in a contemporary STEMI population undergoing PPCI, diabetes is significantly associated with impaired epicardial reperfusion that translates into higher in-hospital and 30-day mortality, particularly during the pandemic.